nanosciences and nanotechnologies: european action 2005-2009 eva hellsten european commission dg...
TRANSCRIPT
Nanosciences and Nanosciences and nanotechnologies: nanotechnologies: European ActionEuropean Action
2005-20092005-2009
Eva HellstenEva HellstenEuropean CommissionEuropean Commission
DG EnvironmentDG Environment
Relation with EU Action Plan on Relation with EU Action Plan on Environment and HealthEnvironment and Health
Action 8 of E&H Action PlanAction 8 of E&H Action Plan
‘‘2004-2006: The Community will work with Member States and 2004-2006: The Community will work with Member States and international organisations, notably the WHO, to…address… international organisations, notably the WHO, to…address… possible environmental and human health impacts of nanoparticles’possible environmental and human health impacts of nanoparticles’
Policy is being developed under the Communication ‘Policy is being developed under the Communication ‘Nanosciences Nanosciences and nanotechnologies: an Action Plan for Europe 2005-2009’.and nanotechnologies: an Action Plan for Europe 2005-2009’.http://europa.eu.int/eur-lex/lex/LexUriServ/site/en/com/2005/com2005_0243en01.pdfhttp://europa.eu.int/eur-lex/lex/LexUriServ/site/en/com/2005/com2005_0243en01.pdf
This presentation focuses on the work plan outlined in this This presentation focuses on the work plan outlined in this Nanotechnology Action Plan, and the state of play on Nanotechnology Action Plan, and the state of play on implementation. References to the ‘Action Plan’ from now on are to implementation. References to the ‘Action Plan’ from now on are to the Nanotech Action Plan.the Nanotech Action Plan.
Setting the scene….Setting the scene….
Breakthrough in science - ability to control matter at the Breakthrough in science - ability to control matter at the atomic levelatomic level
Widespread industrial applications for materials and Widespread industrial applications for materials and devices with new properties due to the small sizedevices with new properties due to the small size
Developed and introduced into the market with high Developed and introduced into the market with high speed all over the world.speed all over the world.
Huge benefits, but uncertainties about health, safety and Huge benefits, but uncertainties about health, safety and environment aspects….environment aspects….
Huge potential benefits…….Huge potential benefits…….
Economic development, boost for R&D and Economic development, boost for R&D and industrial innovation – Lisbon agenda industrial innovation – Lisbon agenda
Technical innovations to increase social welfare Technical innovations to increase social welfare – medicinal applications, electronics, durable – medicinal applications, electronics, durable materials etc.materials etc.
Sustainable development through less energy Sustainable development through less energy and material input, and environment remediationand material input, and environment remediation
……..but also concern about ..but also concern about potential impactspotential impacts…………
Free nanoparticles potentially harmful to health Free nanoparticles potentially harmful to health and environment (reactivity, penetration into and environment (reactivity, penetration into body, brain and cells, PBT properties?)body, brain and cells, PBT properties?)
Unknown exposures (workplaces, consumers, Unknown exposures (workplaces, consumers, via environment or food-chain?)via environment or food-chain?)
Long term concerns for non-ethical applicationsLong term concerns for non-ethical applications
The European Approach….The European Approach…. …. …. aa safe, integrated and responsible safe, integrated and responsible strategy for N&Nstrategy for N&N….….
Towards a European Strategy for Towards a European Strategy for Nanotechnology adopted in May 2004 Nanotechnology adopted in May 2004
Implementing activities proposed in Implementing activities proposed in the the Action PlanAction Plan for Europe 2005-2009for Europe 2005-2009 adopted in June 2005adopted in June 2005
Nanotechnology in a broader Nanotechnology in a broader policy contextpolicy context
Researchand
Development
Societal Issues
Infrastructure
HumanResources
IndustrialInnovation
Lisbon agenda
Sustainable Development
Health, safety, environmental and
consumer protection
International collaboration
Eight groups of actions divided intoEight groups of actions divided into
1.1. Research, Development and InnovationResearch, Development and Innovation
2.2. Infrastructure and European Poles of ExcellenceInfrastructure and European Poles of Excellence
3.3. Interdisciplinary Human Resources: Europe needs CreativityInterdisciplinary Human Resources: Europe needs Creativity
4.4. Industrial Innovation: From Knowledge to the MarketIndustrial Innovation: From Knowledge to the Market
5.5. Integrating the Societal Dimension: Expectations and Integrating the Societal Dimension: Expectations and ConcernsConcerns
6.6. Public Health, Safety, Environment and Consumer ProtectionPublic Health, Safety, Environment and Consumer Protection
7.7. International CooperationInternational Cooperation
8.8. Implementing a Coherent Approach at European LevelImplementing a Coherent Approach at European Level
What has COM done so far?What has COM done so far?
R&D investments under 4-6R&D investments under 4-6thth FP – FP – supporting innovation, education, centres supporting innovation, education, centres of excellence, SMEs; including health and of excellence, SMEs; including health and safety aspectssafety aspects
Addressing environment and health Addressing environment and health concerns (chapter 6)concerns (chapter 6)
Promoting and participating in international Promoting and participating in international collaborationcollaboration
R&D investments under the R&D investments under the Framework ProgrammesFramework Programmes
FP4 1994-1998 FP4 1994-1998 120 M€ 120 M€
FP5 1998-2002 FP5 1998-2002 280 M€ 280 M€
FP6 2002-2006 FP6 2002-2006 13001300 M€ M€
2005~460 € millionestimated
NMP, 209.01
IST, 175.11
Marie Curie, 39.73
NEST, 8.15
Infrastructure, 16.46ERA-NET, 2.20
SMEs, 8.14Science and Society, 1.09
Growth of Support for Nanotech at Growth of Support for Nanotech at EU LevelEU Level
0
50
100
150
200
250
300
350
400
450
500
1997 1998 1999 2000 2001 2002 2003 2004 2005
Pu
bli
c F
un
din
g (
€)
FP4
FP5
FP6
Source: European Commission (2005)
R&
D e
xpen
dit
ure
( M
€)R
&D
exp
end
itu
re (
M€)
Areas Supported by the FPsAreas Supported by the FPs
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
FP4 FP5 FP6
Health / Environment
Research Training
Nanotools
Nanoelectronics
Nanobio / Nanomedicine
Nanomaterials
Frontier Research
As comparison - R&D expenditures As comparison - R&D expenditures world-wide 2004world-wide 2004
R&
D e
xpen
dit
ure
( M
€ )
R&
D e
xpen
dit
ure
( M
€ )
Source: European Commission (2005)
Public540
Public750
Federal910
EC370
States333
MemberStates +
Associated980
Private370
Private1540
Private1700
Private580
0
1,000
2,000
3,000
Europe US Japan Others
Pu
bli
c R
&D
In
vest
men
t (€
)
Action Plan on Environment and Action Plan on Environment and Health Safety issues Chapter 6Health Safety issues Chapter 6
Improve Improve knowledge baseknowledge base - definitions, - definitions, measurements, toxicological and measurements, toxicological and ecotoxicological test methods, exposures, ecotoxicological test methods, exposures, risk assessmentrisk assessment
Regulatory aspectsRegulatory aspects – inventory of existing – inventory of existing legislationlegislation
Expected Opinion from the Expected Opinion from the Scientific Committee Scientific Committee
(SCENIHR) in October 2005(SCENIHR) in October 2005on assessment of on assessment of
risks and methodologiesrisks and methodologies
Environment and Health - filling Environment and Health - filling knowledge gapsknowledge gaps
Workshops:Workshops: A Preliminary Risk Analysis A Preliminary Risk Analysis
(March 2004)(March 2004) Research Needs for Research Needs for
Nanoparticles (Jan 2005)Nanoparticles (Jan 2005)
E&H in Research ProgrammesE&H in Research Programmes
NANOSAFENANOSAFE NANODERMNANODERM NANOPATHOLOGYNANOPATHOLOGY MAAPHRIMAAPHRI NANOFORUMNANOFORUM NANOTOXNANOTOX IMPARTIMPART NANOSAFE2NANOSAFE2
7th Framework Programme 7th Framework Programme
Technological Platforms Technological Platforms
>8M€
~2.5M€
New structures form completely new classes of materials
That will be used in many industrial sectors – lifecycle perspective
Material processing
Manufacture Use RecoveryDistribution
ReuseRecycle
WasteRaw material
Inventory of current legislationInventory of current legislation
Chemicals legislation:Chemicals legislation: NewNew andand existingexisting substances substances legislationlegislation to generate data, safety measures, like to generate data, safety measures, like classification and labelling, and risk management. Will classification and labelling, and risk management. Will likely be replaced by REACH and GHS.likely be replaced by REACH and GHS.
Pharmaceuticals, Pesticides, BiocidesPharmaceuticals, Pesticides, Biocides – authorisation – authorisation schemesschemes
Medical devices, cosmetics, food additives and Medical devices, cosmetics, food additives and packages packages
Worker protectionWorker protection
Air, Water, IPPC, Seveso, Waste, Environment Air, Water, IPPC, Seveso, Waste, Environment Liability, Product liability, Product safetyLiability, Product liability, Product safety
Identifying knowledge gaps from Identifying knowledge gaps from an E&H perspectivean E&H perspective
nomenclature, definitions, nomenclature, definitions, hazard characterisation;hazard characterisation; exposure and effects assessment; exposure and effects assessment; fate, transport, persistence etc. in fate, transport, persistence etc. in
environmental media;environmental media; measurement, sampling and monitoring;measurement, sampling and monitoring;
Some events in 2005Some events in 2005
FebrFebr UK Government: National AgendaUK Government: National AgendaJuneJune OECD Chemicals Committee: Special Session on OECD Chemicals Committee: Special Session on
potential implications of nanomaterials. potential implications of nanomaterials. JuneJune EU Commission: An Action Plan for EU 2005-09EU Commission: An Action Plan for EU 2005-09JuneJune US EPA: Proposal for a voluntary notification US EPA: Proposal for a voluntary notification
scheme under the chemicals legislation (TCSA)scheme under the chemicals legislation (TCSA)JulyJuly International dialogue in Brussels on collaboration International dialogue in Brussels on collaboration
in in R&D (25 countries)R&D (25 countries)OctOct Germany: Stakeholders conference in BonnGermany: Stakeholders conference in BonnOctOct UK presidency workshopUK presidency workshopDecDec 22ndnd OECD workshop in Washington OECD workshop in Washington
Challenges for policy makersChallenges for policy makers
To strike the right balance between To strike the right balance between
Creating a good climate and conditions for Creating a good climate and conditions for innovation and development of applications, innovation and development of applications, contributing to economic growth, welfare and contributing to economic growth, welfare and sustainable developmentsustainable development
Ensuring that potential risks to environment and Ensuring that potential risks to environment and human health, as well as public and ethical human health, as well as public and ethical concerns, are looked into and dealt with at an concerns, are looked into and dealt with at an early stageearly stage